Eric Lagasse

Eric Lagasse, PharmD, PhD is a Co-Founder and and the Chief Science Officer of LyGenesis. As a scientist, he has over 30 years of experience in research development funded by the federal government (NIH, DoD), private foundations, and for-profit biotech companies. Dr. Lagasse worked at Ciba Geigy AG (now Novartis) during his PhD and postdoctoral training. He subsequently joined StemCells Inc. as the Director of their liver stem cell program, in Palo Alto, California. StemCells was one of the first biotech companies to be granted an IND for human clinical trials for CNS neural stem cells transplantation into patients.

Dr. Lagasse earned his Pharmacy Degree and Diplôme d'État de docteur en pharmacie from the University Louis Pasteur in Strasbourg, France; and his PhD with Summa Cum Laude from the Biozentrum, University of Basel, Switzerland. He completed a postdoctoral fellowship at Stanford University in the School of Medicine before accepting a position of Assistant Professor at the University of Pittsburgh School of Medicine. Dr. Lagasse is the author of more than 60 peer-reviewed publications in addition to reviews and book chapters. His work has been cited over 11,000 times with issued and pending patents.